Janus Henderson Group PLC Has $506.55 Million Stock Position in Medline $MDLN

Janus Henderson Group PLC boosted its position in Medline (NASDAQ:MDLN) by 8.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,451,861 shares of the company’s stock after acquiring an additional 887,240 shares during the period. Janus Henderson Group PLC’s holdings in Medline were worth $506,546,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Sound Income Strategies LLC bought a new stake in shares of Medline during the fourth quarter valued at approximately $25,000. Entrust Financial LLC bought a new position in shares of Medline in the 4th quarter worth $26,000. NBC Securities Inc. acquired a new stake in Medline in the 4th quarter valued at $28,000. Whipplewood Advisors LLC bought a new stake in Medline during the 1st quarter valued at $30,000. Finally, Global Retirement Partners LLC bought a new stake in Medline during the 4th quarter valued at $31,000.

Analysts Set New Price Targets

A number of research firms have weighed in on MDLN. Tigress Financial raised their price objective on shares of Medline from $60.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Citigroup decreased their target price on shares of Medline from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Weiss Ratings lowered shares of Medline from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, July 23rd. Barclays dropped their price target on shares of Medline from $50.00 to $45.00 and set an “overweight” rating on the stock in a research report on Monday, June 1st. Finally, BTIG Research reissued a “buy” rating and set a $55.00 price objective on shares of Medline in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $50.54.

Insider Activity

In other news, insider Jessi L. Corcoran acquired 5,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was purchased at an average price of $34.15 per share, for a total transaction of $170,750.00. Following the purchase, the insider owned 5,000 shares in the company, valued at approximately $170,750. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Douglas P. Golwas sold 100,000 shares of Medline stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $36.77, for a total transaction of $3,677,000.00. Following the transaction, the insider directly owned 23,899 shares in the company, valued at approximately $878,766.23. This represents a 80.71% decrease in their position. The SEC filing for this sale provides additional information. 0.81% of the stock is currently owned by insiders.

Medline Price Performance

MDLN opened at $40.08 on Thursday. The company has a debt-to-equity ratio of 0.65, a current ratio of 4.41 and a quick ratio of 2.51. The company has a market capitalization of $52.65 billion and a price-to-earnings ratio of 125.25. The firm’s fifty day moving average price is $38.00 and its two-hundred day moving average price is $41.94. Medline has a 1 year low of $32.81 and a 1 year high of $50.88.

Medline (NASDAQ:MDLN) last announced its earnings results on Wednesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.29 by $0.04. The firm had revenue of $7.35 billion during the quarter. Medline’s quarterly revenue was up 10.7% on a year-over-year basis. As a group, analysts anticipate that Medline will post 1.49 earnings per share for the current fiscal year.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.